Friday, 29 August 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 29 August 2025
Ascott 1
Ascott 1
Patients pick best Aussie pharma

Patients have voted this company the best Big Pharma in Australia and New Zealand when it comes to corporate reputation. Find out why.

Govt delivers new access blow
Commonwealth rejects recommendations to broaden indication coverage for drugs treating rare cancers
TODAY
'Eye opening' Roche data released
Key findings from a company survey released in the lead up to the APAC Roche Ophthalmology Week meeting in Melbourne
TODAY
PiF advertise
PiF advertise
One pharma on Best Workplace list
A lone pharma company alongside a well-known patient advocacy group have made the prestigious national list this year
28 August
Four pharmas to topple Roche
Report reveals the potential rise and fall of the top 10 companies in worldwide prescription drug sales from 2024 to 2030
27 August
Bayer signs deal with Arrotex
Hands over sales, marketing and distribution for a high-profile and long-established franchise in Australia
26 August
Pharma faces heat over 'secret deal'
Independent MP takes to the floor of Federal Parliament demanding transparency around a government deal with Moderna
26 August
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (12)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (6)

Other (14)

What tops the best work perks?
Great Place to Work General Manager reveals staggering insights about what really shifts the dial
28 August
Blockbuster combo's new target
Phase 3 results show the first pharmaceutical regimen that improves survival rates for this cancer population
28 August
Look who's returned to industry
There's been a string of high-level appointments, but a few senior leaders are remaining tight-lipped about their next move
28 August
Blockbuster scores new indication
One of the biggest drugs in the world has earned another tick from the FDA, the question now, will the TGA follow suit?
28 August
Fallen blockbusters of top pharmas
The billions of revenue lost from once top-earning blockbusters, and how the largest pharmas replaced the missing earnings
27 August
BMS offers cancer journey support
Culturally appropriate educational resources aim to help First Nations Australians diagnosed with cancer and their carers
27 August
mRNA deal stays under wraps
Despite a scathing attack by Independents, the Govt and Opposition show overwhelming support for the Moderna deal
27 August
New face joins GBMA Board
Who's been appointed to the industry organisation's Board of Directors as Teva's ANZ General Manager Jim Margaritis exits?
27 August
Partners picked for $60M plan
World-leading tech companies to help build a new AI-powered supercomputer that could generate a new wave of medicines
26 August
'Frustrated and confused' by PBAC
Fighting words: more organisations join the pushback against PBAC rejections as industry becomes increasingly vocal
26 August
Vaping opens up a new market
The first TGA approved treatment to combat cravings for Australians who are looking to break free from the vaping habit
26 August
Pharma pulls drug over pricing
After a second rejection, this company has announced its first-in-class treatment won't be made available to Australian patients
25 August
AZ hosts Girls to Graduates event
Collaboration with Macquarie University to shine a light on the career paths available to women studying STEMM
25 August
'Simply not good enough, PBAC'
Rejected for a multi-indication listing for its cancer blockbuster, the company says the goal posts were moved
25 August
PiF Jobs
PiF Jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.